Nanocarriers for biomedicine: From lipid formulations to inorganic and hybrid nanoparticles
R Kashapov, A Ibragimova, R Pavlov… - International Journal of …, 2021 - mdpi.com
Encapsulation of cargoes in nanocontainers is widely used in different fields to solve the
problems of their solubility, homogeneity, stability, protection from unwanted chemical and …
problems of their solubility, homogeneity, stability, protection from unwanted chemical and …
Gastrointestinal permeation enhancers for the development of oral peptide pharmaceuticals
JC Kim, EJ Park, DH Na - Pharmaceuticals, 2022 - mdpi.com
Recently, two oral-administered peptide pharmaceuticals, semaglutide and octreotide, have
been developed and are considered as a breakthrough in peptide and protein drug delivery …
been developed and are considered as a breakthrough in peptide and protein drug delivery …
Linolenic acid conjugated chitosan micelles for improving the oral absorption of doxorubicin via fatty acid transporter
Y Yang, Y Chen, D Li, S Lin, H Chen, W Wu… - Carbohydrate …, 2023 - Elsevier
A novel delivery system based on linolenic acid (LA) conjugated chitosan (CS) polymeric
micelles were proposed for improving the oral absorption of doxorubicin (DOX) through …
micelles were proposed for improving the oral absorption of doxorubicin (DOX) through …
Use of novel taurine-chitosan mediated liposomes for enhancing the oral absorption of doxorubicin via the TAUT transporter
S Qin, Z Wen, H Huang, W Wu - Carbohydrate Polymers, 2024 - Elsevier
Our research aimed to enhance the oral bioavailability of doxorubicin hydrochloride (DOX·
HCl) while minimizing the potential for myocardial toxicity. To achieve this goal, we …
HCl) while minimizing the potential for myocardial toxicity. To achieve this goal, we …
Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor
Glioblastoma multiforme (GBM) is a central nervous system disease with poor prognosis.
Curative treatments for GBM involve chemotherapy, radiotherapy, and surgical pathways …
Curative treatments for GBM involve chemotherapy, radiotherapy, and surgical pathways …
Peptide permeation enhancers for improving oral bioavailability of macromolecules
D Kim, L Jin, EJ Park, DH Na - Journal of Pharmaceutical Investigation, 2023 - Springer
Background Oral delivery of macromolecules has been limited mainly by their low intestinal
permeability. Chemical permeation enhancers (CPEs) are typically used to improve …
permeability. Chemical permeation enhancers (CPEs) are typically used to improve …
Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery
Background Despite the effectiveness of glucagon-like peptide-1 agonist (GLP-1A) in the
treatment of diabetes, its large molecular weight and high hydrophilicity result in poor …
treatment of diabetes, its large molecular weight and high hydrophilicity result in poor …
Measurement and correlation of solubility of rivaroxaban in dichloromethane and primary alcohol binary solvent mixtures at different temperatures
The solubility of rivaroxaban in different solvent mixtures consisting of dichloromethane and
primary alcohols, including methanol, ethanol, n-propanol, and n-butanol, was evaluated …
primary alcohols, including methanol, ethanol, n-propanol, and n-butanol, was evaluated …
Advancements in 5-Fluorouracil-Loaded Liposomal Nanosystems: A Comprehensive Review on Recent Innovations in Nanomedicine for Cancer Therapy
MS Ali, SK Jha, G Gupta, A Alsayari, S Wahab… - Journal of Drug Delivery …, 2024 - Elsevier
The increasing worldwide cancer prevalence is a result of population aging and expansion
and changes in individuals' exposure to risk factors, many of which are linked to …
and changes in individuals' exposure to risk factors, many of which are linked to …
Enhancement of the anticancer effect of atorvastatin-loaded nanoemulsions by improving oral absorption via multivalent intestinal transporter-targeting lipids
Atorvastatin (ATV) has attracted considerable attention as a potential therapeutic agent for
cancer because it inhibits cancer cell proliferation by suppressing the mevalonate pathway …
cancer because it inhibits cancer cell proliferation by suppressing the mevalonate pathway …